SARL LABORATOIRE SUREL : revenue, balance sheet and financial ratios

SARL LABORATOIRE SUREL is a French company founded 30 years ago, specialized in the sector Fabrication de matériel médico-chirurgical et dentaire. Based in MOISDON-LA-RIVIERE (44520), this company of category PME shows in 2022 a revenue of 1.2 M€. Find below the complete financial statements, solvency ratios, working capital requirements and sector comparison.

Data updated on 2026-05-09

Sources : INPI & INSEE SIRENE - Processing : Ministry of Economy

Financial history - SARL LABORATOIRE SUREL (SIREN 404226540)
Indicator 2025 2024 2023 2022 2020 2019 2018 2017 2016
Revenue N/C N/C N/C 1 169 787 € N/C N/C N/C N/C 914 876 €
Net income 179 310 € 232 386 € 211 812 € 178 164 € 49 429 € 71 127 € 32 064 € 35 329 € 32 373 €
EBITDA N/C N/C N/C 269 128 € N/C N/C N/C N/C 19 937 €
Net margin N/C N/C N/C 15.2% N/C N/C N/C N/C 3.5%

Revenue and income statement

Im Jahr 2025 erzielt SARL LABORATOIRE SUREL ein positives Nettoergebnis von 179 k€. Entwicklung 2016-2025: 32 k€ -> 179 k€.

Net income (2025) ?
Net income
Definition
Profit or loss after all expenses, including taxes and exceptional items.
Formula
Current income + Exceptional income - Income tax

179 310 €

Loading income statement...

Chart evolution

Show :

Assets

Loading data...

Liabilities

Loading data...

Solvency and debt ratios

Die Verschuldungsquote (= Finanzschulden / Eigenkapital x 100) beträgt 34%. Die Verschuldung bleibt unter Kontrolle. Die finanzielle Autonomie (= Eigenkapital / Bilanzsumme x 100) erreicht 66%. Diese hohe Autonomie bedeutet, dass das Unternehmen den Großteil seiner Vermögenswerte durch Eigenkapital finanziert.

Debt ratio (2025) ?
Debt ratio
Definition
Measures the proportion of debt to equity.
Formula
(Financial debt / Equity) x 100
Interpretation
< 50% : Low
50-100% : Moderate
> 100% : High

34.433%

Financial autonomy (2025) ?
Financial autonomy
Definition
Share of equity in the company's total financing.
Formula
(Equity / Total assets) x 100
Interpretation
> 30% : Good autonomy
20-30% : Average
< 20% : Low

65.921%

Asset age ratio (2025) ?
Asset age ratio
Definition
Measures the degree of wear of tangible assets.
Formula
Accumulated depreciation / Gross fixed assets x 100
Interpretation
< 50% : Recent assets
50-70% : Normal wear
> 70% : Aging assets

32.0%

Solvency indicators evolution
SARL LABORATOIRE SUREL

Sector positioning

Verschuldungsgrad
34.43 2025
2023
2024
2025
Q1: 5.49
Med: 17.07
Q3: 41.92
Average +7 pts over 3 years

Im Jahr 2025 liegt über dem Median der Branche das verschuldungsgrad von SARL LABORATOIRE SUREL (34.43). Dieses Verhältnis misst das Gewicht der Schulden im Verhältnis zum Eigenkapital. Eine Reduzierung könnte die finanzielle Stärke verbessern.

Finanzielle Autonomie
65.92% 2025
2023
2024
2025
Q1: 36.67%
Med: 56.53%
Q3: 69.09%
Gut

Im Jahr 2025 liegt über dem Median der Branche das finanzielle autonomie von SARL LABORATOIRE SUREL (65.9%). Dieses Verhältnis stellt den Anteil des Eigenkapitals an der Gesamtfinanzierung dar. Diese komfortable Position bietet eine nennenswerte Sicherheitsmarge.

Liquidity ratios

Die Liquiditätsquote beträgt 409.96. Das Unternehmen verfügt über 2€ liquide Mittel für jeden 1€ kurzfristiger Schulden.

Liquidity ratio (2025) ?
Liquidity ratio
Definition
Ability to meet short-term debts with current assets.
Formula
Current assets / Current liabilities
Interpretation
> 1.5 : Very good
1-1.5 : Fair
< 1 : Liquidity risk

409.963

Liquidity indicators evolution
SARL LABORATOIRE SUREL

Sector positioning

Liquiditätsquote
409.96 2025
2023
2024
2025
Q1: 181.98
Med: 251.18
Q3: 365.98
Ausgezeichnet

Im Jahr 2025 liegt in den oberen 25% der Branche das liquiditätsquote von SARL LABORATOIRE SUREL (409.96). Dieses Verhältnis misst die Fähigkeit, kurzfristige Schulden mit Umlaufvermögen zu decken. Ein Verhältnis über 1 gewährleistet komfortable Deckung kurzfristiger Fälligkeiten.

Working capital requirement (WCR) and payment terms

Der Betriebskapitalbedarf (WCR) misst die zeitliche Lücke.

Operating WCR (2025) ?
Operating WCR
Definition
Financing requirement generated by the operating cycle (inventory + receivables - trade payables).
Formula
Inventory + Customer receivables - Trade payables
Interpretation
Negative = cash released
Positive = financing needed

0 €

Customer credit (2025) ?
Customer credit (days)
Definition
Average payment term granted to customers.
Formula
(Customer receivables / Revenue incl. VAT) x 360
Interpretation
< 45j : Good
45-60j : Average
> 60j : Long

0 j

Supplier credit (2025) ?
Supplier credit (days)
Definition
Average payment term obtained from suppliers.
Formula
(Trade payables / Purchases incl. VAT) x 360
Interpretation
The longer the term, the better for cash flow

0 j

Inventory turnover (2025) ?
Inventory turnover (days)
Definition
Average storage duration for goods or materials.
Formula
(Inventory / Cost of goods) x 360
Interpretation
The lower the ratio, the faster the turnover

0 j

WCR and payment terms evolution
SARL LABORATOIRE SUREL

Positioning of SARL LABORATOIRE SUREL in its sector

Comparison with sector Fabrication de matériel médico-chirurgical et dentaire

Valuation estimate

Based on 57 transactions of similar company sales (all years), the value of SARL LABORATOIRE SUREL is estimated at 546 120 € (range 126 911€ - 1 076 926€). This multiples method compares the actual sale price of similar companies to their financial indicators (Revenue, EBITDA, Net Income). It provides a market-based indicative estimate.
Medium reliability: estimate to be confirmed with in-depth analysis.

Estimated enterprise value 2025
57 tx
126k€ 546k€ 1076k€
546 120 € Range: 126 911€ - 1 076 926€
NAF 5 all-time

Valuation method used

Net Income Multiple
179 310 € × 3.0x = 546 121 €
Range: 126 912€ - 1 076 926€

Only this financial indicator is available for this company.

How is this estimate calculated?

This estimate is based on the analysis of 57 actual transactions of similar company sales (same NAF code) registered with BODACC between 2016 and 2025.

  • EBITDA Multiple: Preferred method for profitable SMEs. EBITDA reflects the ability to generate cash.
  • Revenue Multiple: Used for growing companies or those with low profitability. Reflects commercial potential.
  • Net Income Multiple: Relevant for mature companies with stable results.

This estimate is provided for information purposes only. A precise valuation requires in-depth analysis (assets, liabilities, prospects, market...).

Similar companies (Fabrication de matériel médico-chirurgical et dentaire)

Compare SARL LABORATOIRE SUREL with other companies in the same sector:

Voir toutes les statistiques du secteur Fabrication de matériel médico-chirurgical et dentaire

Frequently asked questions about SARL LABORATOIRE SUREL

What is the revenue of SARL LABORATOIRE SUREL ?

The revenue of SARL LABORATOIRE SUREL in 2022 is 1.2 M€.

Is SARL LABORATOIRE SUREL profitable?

Yes, SARL LABORATOIRE SUREL generated a net profit of 179 k€ in 2025.

Where is the headquarters of SARL LABORATOIRE SUREL ?

The headquarters of SARL LABORATOIRE SUREL is located in MOISDON-LA-RIVIERE (44520), in the department Loire-Atlantique.

Where to find the tax return of SARL LABORATOIRE SUREL ?

The tax return of SARL LABORATOIRE SUREL is available on this page. Click on a year in the 'Data by year' section to view the account details (assets, liabilities, income statement). Data comes from INPI (National Institute of Industrial Property).

In which sector does SARL LABORATOIRE SUREL operate?

SARL LABORATOIRE SUREL operates in the sector Fabrication de matériel médico-chirurgical et dentaire (NAF code 32.50A). See the 'Sector positioning' section above to compare the company with its competitors.